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Supplemental Data : Survey Questions, Case Scenarios and Answers 
 
Question 1.  Do you work in a hyperacute or acute stroke unit caring for patients within the first few 

















































Question 5. Would you be willing to randomise patients with non-valvular atrial fibrillation (AF) and 



















Question 7. Would you be more comfortable randomsing patients to a trial of early OAC use after 















   
 
Question 9. Do you use the 1-3-6-12 rule outlined in the European Society of Cardiology (ESC) AF 







Question 10. If you do not use the 1-3-6-12 rule, how do you decide when to start OAC? (See 







Case 1: TIA 
A 76 year old male presents with a left hemisphere TIA lasting for 30 minutes. Plain CT brain shows 
no obvious abnormality. Cardiovascular risk factors include hypertension and ischaemic heart 
disease. His ECG shows shows AF. Assume there are no contraindications to long term 
anticoagulation in your answers. 
 
Question 11. When do you currently start OAC drugs after a TIA in patients with AF? (Day of TIA is 
considered as Day 0) 
Rank value Option Count 
1 Day 0 94 
2 Day 1 25 
3 Day 2 1 
4 Day 3 1 
5 Day 4 0 
6 Day 5 0 
7 Day 6 0 
8 Day 7 0 
9 Day 8 0 
10 Day 9 0 
11 Day 10 0 
12 Day 11 0 
13 Day 12 0 
14 Day 13 0 
15 Day14 0 
16 Day 15 0 
17 Day 16 0 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 




Question 12. When would be the earliest time (acceptable to you) to start OAC drugs in a trial after 
TIA in patients with AF? (Day of TIA is considered as Day 0) 
Rank value Option Count 
1 Day 0 104 
2 Day 1 16 
3 Day 2 1 
4 Day 3 0 
5 Day 4 0 
6 Day 5 0 
7 Day 6 0 
8 Day 7 0 
9 Day 8 0 
10 Day 9 0 
11 Day 10 0 
12 Day 11 0 
13 Day 12 0 
14 Day 13 0 
15 Day 14 0 
16 Day 15 0 
17 Day 16 0 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 





Question 13. When would be the latest time (acceptable to you) to start OAC drugs in a trial after 











Rank value Option Count 
1 Day 0 37 
2 Day 1 32 
3 Day 2 12 
4 Day 3 15 
5 Day 4 2 
6 Day 5 2 
7 Day 6 0 
8 Day 7 13 
9 Day 8 0 
10 Day 9 0 
11 Day 10 2 
12 Day 11 0 
13 Day 12 0 
14 Day 13 1 
15 Day14 3 
16 Day 15 0 
17 Day 16 0 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 
21 Day 20 2 
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Case 2: Mild Stroke 
A 76 year old male presents with right sided weakness. He has a NIHSS score of 4. A CT scan of the 
brain reveals a cortical lesion of <1.5 cm in the left middle cerebral artery territory. Cardiovascular 
risk factors include hypertension and ischaemic heart disease. BP and bloods are unremarkable. 
ECG shows AF. Assume there are no contraindications to long term anticoagulation in your 
answers. 
 
Question 14. When do you currently start OAC drugs after a mild stroke in patients with AF? (Day of 
stroke is considered as Day 0) 
Rank value Option Count 
1 Day 0 12 
2 Day 1 9 
3 Day 2 6 
4 Day 3 36 
5 Day 4 11 
6 Day 5 4 
7 Day 6 8 
8 Day 7 24 
9 Day 8 0 
10 Day 9 1 
11 Day 10 1 
12 Day 11 0 
13 Day 12 0 
14 Day 13 0 
15 Day14 8 
16 Day 15 1 
17 Day 16 0 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 




Question 15. When would be the earliest time (acceptable to you) to start OAC drugs in a trial after a 
mild stroke in patients with AF? (Day of stroke is considered as Day 0) 
Rank value Option Count 
1 Day 0 40 
2 Day 1 19 
3 Day 2 7 
4 Day 3 32 
5 Day 4 7 
6 Day 5 3 
7 Day 6 1 
8 Day 7 8 
9 Day 8 0 
10 Day 9 0 
11 Day 10 0 
12 Day 11 0 
13 Day 12 0 
14 Day 13 0 
15 Day 14 2 
16 Day 15 1 
17 Day 16 0 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 









Question 16. When would be the latest time (acceptable to you) to start OAC drugs in a trial after a 







Rank value Option Count 
1 Day 0 2 
2 Day 1 1 
3 Day 2 2 
4 Day 3 13 
5 Day 4 3 
6 Day 5 9 
7 Day 6 5 
8 Day 7 35 
9 Day 8 0 
10 Day 9 1 
11 Day 10 6 
12 Day 11 1 
13 Day 12 1 
14 Day 13 1 
15 Day14 37 
16 Day 15 2 
17 Day 16 0 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 
21 Day 20 2 
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Case 3: Moderate Stroke 
A 76 year-old male presents with right sided weakness and dysarthria. He has a NIHSS score of 8.  
CT brain reveals a lesion in a cortical superficial branch of the middle cerebral artery in the left 
hemisphere. Cardiovascular risk factors include hypertension and ischaemic heart disease. ECG 
shows AF. Assume there are no contraindications to long term anticoagulation in your answers. 
 
Question 17. When do you currently start OAC drugs after a moderate stroke in patients with AF? 
(Day of stroke is considered as Day 0) 
Rank value Option Count 
1 Day 0 4 
2 Day 1 0 
3 Day 2 3 
4 Day 3 7 
5 Day 4 3 
6 Day 5 9 
7 Day 6 15 
8 Day 7 43 
9 Day 8 2 
10 Day 9 1 
11 Day 10 7 
12 Day 11 1 
13 Day 12 3 
14 Day 13 0 
15 Day14 21 
16 Day 15 1 
17 Day 16 0 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 




Question 18. When would be the earliest time (acceptable to you) to start OAC drugs in a trial after a 
moderate stroke in patients with AF? (Day of stroke is considered as Day 0) 
Rank value Option Count 
1 Day 0 20 
2 Day 1 5 
3 Day 2 7 
4 Day 3 21 
5 Day 4 3 
6 Day 5 14 
7 Day 6 7 
8 Day 7 27 
9 Day 8 0 
10 Day 9 1 
11 Day 10 5 
12 Day 11 0 
13 Day 12 0 
14 Day 13 0 
15 Day 14 7 
16 Day 15 1 
17 Day 16 0 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 







Question 19. When would be the latest time (acceptable to you) to start OAC drugs in a trial after a 







Rank value Option Count 
1 Day 0 1 
2 Day 1 0 
3 Day 2 0 
4 Day 3 1 
5 Day 4 0 
6 Day 5 1 
7 Day 6 3 
8 Day 7 17 
9 Day 8 0 
10 Day 9 5 
11 Day 10 15 
12 Day 11 1 
13 Day 12 3 
14 Day 13 1 
15 Day14 61 
16 Day 15 6 
17 Day 16 1 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 
21 Day 20 4 
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Case 4: Severe Stroke 
A 76 year old male presents with right sided weakness, hemianopia and dysphasia. He has a NIHSS 
score of 18. Brain CT shows hypodensity changes in most of the left middle cerebral artery 
territory, consistent with acute infarction. Cardiovascular risk factors include hypertension and 
ischaemic heart disease. ECG shows AF. Assume there are no contraindications to long term 
anticoagulation in your answers. 
 
Question 20. When do you think is the ideal time to start OAC drugs after severe stroke in patients 
with AF? (Day of stroke is considered as Day 0) 
Rank value Option Count 
1 Day 0 0 
2 Day 1 0 
3 Day 2 1 
4 Day 3 0 
5 Day 4 1 
6 Day 5 0 
7 Day 6 0 
8 Day 7 9 
9 Day 8 1 
10 Day 9 1 
11 Day 10 13 
12 Day 11 1 
13 Day 12 8 
14 Day 13 1 
15 Day14 73 
16 Day 15 7 
17 Day 16 1 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 




Question 21. When would be the earliest time (acceptable to you) to start OAC drugs in a trial after 







Rank value Option Count 
1 Day 0 7 
2 Day 1 2 
3 Day 2 1 
4 Day 3 7 
5 Day 4 1 
6 Day 5 3 
7 Day 6 1 
8 Day 7 31 
9 Day 8 1 
10 Day 9 1 
11 Day 10 11 
12 Day 11 0 
13 Day 12 7 
14 Day 13 0 
15 Day 14 43 
16 Day 15 3 
17 Day 16 0 
18 Day 17 0 
19 Day 18 0 
20 Day 19 0 
21 Day 20 2 
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Question 22. When would be the latest time (acceptable to you) to start OAC drugs in a trial after 
severe stroke in patients with AF? (Day of stroke is considered as Day 0) 
Rank value Option Count 
1 Day 0 0 
2 Day 1 0 
3 Day 2 0 
4 Day 3 0 
5 Day 4 0 
6 Day 5 0 
7 Day 6 0 
8 Day 7 0 
9 Day 8 0 
10 Day 9 0 
11 Day 10 2 
12 Day 11 1 
13 Day 12 4 
14 Day 13 0 
15 Day14 65 
16 Day 15 9 
17 Day 16 1 
18 Day 17 1 
19 Day 18 1 
20 Day 19 0 









Supplemental Table I: Free text comments regarding how clinicians decide when to 
initiate OAC. 
 
Size of infarct, HT, ischaemic stroke risk, Echo, etc. 
I base timing on an individual assessment taking account of 
size of infarct/severity 
HTI 
likelihood of cardiac embolism 
swallow status 
timing of discharge 
likelihood of falls 
patient/family views 
Similar to 1-3-6-12 rule; based on infarct size etc but more flexible with timings 
Depends on the size of the lesion. For bigger strokes I tend to wait for two weeks, for TIAs with 
normal MR, I tend to start immediately. 
Traditional view of small and large stroke severity 
Extent of infarction 
Clinical judgement 
Stroke severity 
I make the decision based on the size of ischemic lesion in the imaging . 
depending on the size of infarct 
I usually follow 1-3-6-12 rule.Alternatively I intend to start OAC 2 weeks after Stroke if there is a 
large area of infarction but I start as soon as possible if there is minor disability stroke or mild 
ischemic changes in brain imaging. 
usually 2 weeks after stroke or as soon as symptoms resolved 
Minor stoke with low NIHSS <5) and no or smallinforact on CT: immediately, Severe stroke wait 
two weeks. In between minor and severe: varialbe, spendds on patient details. 
Roughly similar, depending on infarct size and patient factors 
Based on a more nuanced judgement of risk versus benefit 
On a patient by patient basis, taking account of blood pressure, bleeding diathesis, infarct size, etc 
Swallowing status, absence of PH2 haemorrhagic transformation 
Based on combination of patient factors and imaging 
clinical judgement 
Clinical judgement by patient 
I use a variation of this - if large infarct on NIHSS or scan I delay up to 14 days 
size of the acute infarct and clinical deficit 
Individualised, largely relating to stroke severity/ underlying extent of infarction, and other factors 
e.g. preceding TIA etc 
Depends upon stroke severity 
Depending on infarct size 
Day 1 for TIA 
Day 7 for mild /moderate stroke 
Day 14 for severe stroke 
size of the infarct on CT Brain. clinically improvement. 
TIA/very minor stroke - start early 
More major stroke- wait for 2 week 
Infarct size and patient clinical condition. 
Use RCP guidelines 
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I am not familiar with this rule. If I find a large infarct on scan I wait 14 days before starting a 
NOAC. If CT is normal or shows a small infarct I usually anticoagulate at 7 days. 
UK RCP/NICE stroke guidance and MDT discussion 
Depends on stroke severity and other factors? NBM ? Other patient risk factors 
Usually either immediately, day 3, 5, 7, 10 or 14 - entirely pragmatic numbers. 
On a case by case basis depending on the volume of ischemic tissue from the infarct 
size of infarct, white matter disease burden, any CAA features on MRI, patient's past history..all 
factored in. In reality what I do is something akin to the 1 3 6 12 rule. 
Size of infarct, other factors such as oral route availability and cardio-embolic risk 
I wait 2 weeks if big stroke with significant lesion on scan and I tend to start immediately if TIA or 
small stroke with minimal scan lesion 
Immediately after TIA, 1 week after small infarct, 2 weeks after large infarct 
Never heard of the rule! In TIA if ICH is excluded and patient has AF I start NOAC straight away. In 
a 'minor stroke' e.g. NIHSS 1 to 3 and no ICH or large volume infarct on scan and patient is high 
risk with AF I often continue or start NOAC very early e.g. 1-2 days 
Individual decision based on size of infarction and Chadsvasc 
Individual case basis, depending on BP and infarct appearance 
default is 2 weeks otherwise depending on the patient 
Based on clinical deficit from stroke or based on volume of infarct on MRI usually, sometimes CT. 
Also risk of further stroke (metal mitral valve or other such pressing indication) 
size of infarct, current disability and medical conditions of patient 
Occasionally not strictly as per above rules depending on size of infarction and risk of 
haemorrhage 
depending on patient clinical history, co morbidities, clinical signs etc 
TIA - straight away 
Minor stroke - one week to 10 days  
Major stroke - 14 days (or more if haem transformation) 
tia or smallish stroke straight away. big stroke 2 weeks, others inbetween but varies 
Immediate for TIA, either at 14 days or on discharge from hospital (whichever comes first) after 
ischaemic stroke. 
Generally, start anticoagulants as soon as possible if infarct size judged small, or no new MRI 
infarct findings in TIA pt 
Severity/size of stroke leading to delay in restarting at least a week 
Presumption of aetiology to be embolic more likely to continue inside same week if TIA 
(I have subsequently reviewed the 1-3-6-12 and find it to be largely in keeping with these 
thoughts as a handy guide) 
Acute infarct - wait for 2 weeks 
normally wait until the 14 days of high dose aspirin has completed before changing to secondary 
prevention with either clopidogrel in non-AF and OAC in AF 
 
I am not aware of the 1-3-6-12 rule! 






Supplemental Table II: Survey general free text comments 
The initiation of OAC depends on following factors:Severity of the Stroke clinically and in NIHSS 
score, Area of ischemic involvement in the imaging and haemorrhagic transformation in ischemic 
area.It is usually 2weeks after moderate to large stroke.In minor disability stroke you can start 
ASAP safely. 
If patient has AF and minor stroke / TIA then we know there's a clot in the atrium at risk of large 
embolus. Thus need to anticoagulated immediately. 
difficult to answer questions as my clinical decision is based on symptom resolution. NIHSS scores 
quoted are on admission and have assumed resolved on 2 milder strokes 
deciding between mild and moderate stroke can be difficult - clinical experience/judgement has 
to come into it rather than wholly protocol 
Indefinite delay could be considered for last case depending on progress, patient/family wishes, 
swallowing status etc. 
We clearly need a trial to provide evidence for best practise. 
If asked a couple of years ago I would have considered this trial. Now I think we have reached and 
equilibrium where we have a reasonable clinical logic as to when to start. It get earlier and earlier. 
A trial with forced delay wouldn't be comfortable to me. 
Consideration of time for patients to consider consent options when early anticoagulation is 
indicated. Should not delay treatment but informed consent will need time. 
Very important to answer the dilemma soon. 
The trail design should include various times of OAC as well as heparinoids left to the clinicians' 
discretion 
The decision to start anticoagulants also depends on co-morbidities and other patient related 
factors and also CT/MRI findings after the acute event. 
I think the question on the latest time to start an anticoagulant is difficult to answer particularly in 
large stroke and depends on the functional recovery/risk of falls which may not be know for some 
time 
DOAC preferable due to reduced risk of ICH as revealed in clinical trials 
Consistency of oral route, renal function may influence choices. A study of early(<7 days) vs 
late(>/14 days OAC would be very helpful-to achieve consistency of OAC would probably have to 
use a NOAC only (Preferable) or LMWH/Wafarin as an option to ensure consistent 
anticoagulation. 
I think in general the safest time to start NOACs after a stroke is after 2 weeks. After TIA it is ASAP. 
Starting OACs is very variable and multiple factors are usually taken into consideration. In general 
we are probably too reticent. 
 
It is a particularly nervous interval after successful thrombectomy in patients with AF as so much 
effort has gone into treating the acute stroke that to have another while waiting for the 
''haemorrhage risk window'' to pass, is a disheartening failure of nerve. 
 
What is also not clear is if patients should or should not be on antiplatelets while waiting the 
appropriate time interval for OACs 
For the more severe stroke, you may not be starting OAC but dalteparin which would need to be 
factored into the equation and might also be an option for more moderate strokes 
The trial should answer whether a second CT scan should be performed especially in severe stroke 
before commencing OAC early 
Clarification on optimal timing would be helpful 
Very content to randomise. There is sufficient uncertainty and presumably this survey will show a 
wide range of responses- we need a trial rather than our 'expert' opinion. 
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this is an excellent area for study - it is common, there is (to me at least) clinical equipoise and I 
think that there is considerable variation in clinician approach 
 
there is a balance to be struck between reversibility and the irreversible nature of anticoagulation 
with low molecular weight heparins and the direct anti-Xa DOACs versus warfarin and the 
predictable anticoagulation provided; there is also a risk/benefit in terms of both risk of 
haemorrhage, risk of further thrombotic stroke and in the more disabled/severe stroke patients 
VTE risk which would also be treated by anticoagulation but are currently not protected by the 
antiplatelet regime 
I'd also be interested in when one might start/restart post intracerebral haemorrhage 
 
